Liangjun Lu

Title: **Innovator Profile: Liangjun Lu**

Introduction

Liangjun Lu is an esteemed inventor based in Kildeer, Illinois, with a prolific career that has led to the development of seven patents. His contributions, particularly in the fields of medicine and biotechnology, underscore his dedication to advancing health care solutions.

Latest Patents

Among Liangjun Lu's notable inventions are his latest patents which include:

1. **Anti-alpha-4-beta-7 antibodies**: This invention consists of antibodies that specifically bind to human alpha-4-beta-7, with implications for HIV treatment. The provided methods of creating these antibodies have the potential to significantly impact therapeutic strategies for individuals living with HIV infection.

2. **Macrocyclic hepatitis C serine protease inhibitors**: This patent involves novel fluorinated macrocyclic compounds aimed at treating hepatitis C infections. It details pharmaceutical compositions that combine these compounds with acceptable carriers or excipients, striving to improve treatment efficacy for patients in need.

Career Highlights

Throughout his career, Liangjun Lu has held valuable positions at reputable companies including Abbott Laboratories Corporation and AbbVie Inc. His innovative work has positioned him as a leading figure in the development of therapeutic agents that combat viral infections.

Collaborations

Liangjun Lu has collaborated with notable professionals such as Todd Warren Rockway and David A. Betebenner, enhancing the collective expertise within his fields of research and product development. These collaborations have played a significant role in supporting his innovative efforts.

Conclusion

With a focus on groundbreaking medical inventions, Liangjun Lu continues to make a substantial impact in the biotechnology sector. His patented work not only reflects his ingenuity but also his commitment to improving patient outcomes in the fight against viral diseases.